Novel human in vitro vegetation simulation model for infective endocarditis

Franziska A. Schwartz*, Lars Christophersen, Anne Sofie Laulund, Rasmus Lundquist, Christian Lerche, Pia Rude Nielsen, Henning Bundgaard, Niels Høiby, Claus Moser

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

9 Citationer (Scopus)
17 Downloads (Pure)

Abstract

Infective endocarditis (IE) is a heart valve infection with high mortality rates. IE results from epithelial lesions, inducing sterile healing vegetations consisting of platelets, leucocytes, and fibrin that are susceptible for colonization by temporary bacteremia. Clinical testing of new treatments for IE is difficult and fast models sparse. The present study aimed at establishing an in vitro vegetation simulation IE model for fast screening of novel treatment strategies. A healing promoting platelet and leucocyte-rich fibrin patch was used to establish an IE organoid-like model by colonization with IE-associated bacterial isolates Staphylococcus aureus, Streptococcus spp (S. mitis group), and Enterococcus faecalis. The patch was subsequently exposed to tobramycin, ciprofloxacin, or penicillin. Bacterial colonization was evaluated by microscopy and quantitative bacteriology. We achieved stable bacterial colonization on the patch, comparable to clinical IE vegetations. Microscopy revealed uneven, biofilm-like colonization of the patch. The surface-associated bacteria displayed increased tolerance to antibiotics compared to planktonic bacteria. The present study succeeded in establishing an IE simulation model with the relevant pathogens S. aureus, S. mitis group, and E. faecalis. The findings indicate that the IE model mirrors the natural IE process and has the potential for fast screening of treatment candidates.

OriginalsprogEngelsk
TidsskriftAPMIS
Vol/bind129
Udgave nummer11
Sider (fra-til)653-662
Antal sider10
ISSN0903-4641
DOI
StatusUdgivet - 2021

Bibliografisk note

Funding Information:
This work was supported by the Novo Nordisk Fonden (NNF17OC0025074) to MD, PhD Claus Moser and the A.P. Møller Fonden (19‐L‐0283) to MD, PhD Christian J. Lerche and the Rigshospitalet introduktionsstipendium (E‐22416‐07) to MSc, Franziska A. Schwartz.

Funding Information:
This work was supported by the Novo Nordisk Fonden (NNF17OC0025074) to MD, PhD Claus Moser and the A.P. M?ller Fonden (19-L-0283) to MD, PhD Christian J. Lerche and the Rigshospitalet introduktionsstipendium (E-22416-07) to MSc, Franziska A. Schwartz. The authors thank Reapplix, especially Niels-Erik Holm and Annette Walter M?rck, for their supply with patch devices. Reapplix had no role in study design, data collection, interpretation, or the decision to submit this work for publication.

Publisher Copyright:
© 2021 Scandinavian Societies for Medical Microbiology and Pathology.

Citationsformater